v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenue $ 8,320 $ 7,569 $ 15,670 $ 16,571
Cost of revenue 5,529 5,990 10,037 11,746
Gross profit 2,791 1,579 5,633 4,825
Operating expenses        
Research and development 914 1,449 1,859 3,005
Sales and marketing 1,448 2,259 2,824 4,591
General and administrative 1,102 1,249 2,312 2,613
Intangible amortization 225 308 451 616
Total operating expenses 3,689 5,265 7,446 10,825
Operating profit (loss) (898) (3,686) (1,813) (6,000)
Other income, net 15 125 45 289
Income (loss) before income taxes (883) (3,561) (1,768) (5,711)
Income tax benefit (expense) (2) 0 58 (7)
Net income (loss) (1) [1] $ (885) $ (3,561) $ (1,710) $ (5,718)
Basic $ (0.06) $ (0.23) $ (0.11) $ (0.37)
Diluted $ (0.06) $ (0.23) $ (0.11) $ (0.37)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 900 900 900 900
Weighted-average number of common shares outstanding:        
Basic (shares) 15,726 15,512 15,695 15,483
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options (2) [2] 0 0 0 0
Diluted (shares) 15,726 15,512 15,695 15,483
[1] Net income (loss) and comprehensive income (loss) are the same for the periods reported.
[2] The Company had 0.9 million shares represented by common stock equivalents for the three and six months ended September 30, 2020 and September 30, 2019, which were not included in the computation of average dilutive shares outstanding because they were anti-dilutive. In periods with a net loss from continuing operations, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation.

Source